Long Focus Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-720,000
| Closed | -$34.2M | – | 94 |
|
|
2025
Q3 | $34.2M | Hold |
720,000
| – | – | 1.95% | 26 |
|
|
2025
Q2 | $38.4M | Sell |
720,000
-9,504
| -1% | -$432K | 2.48% | 15 |
|
|
2025
Q1 | $29.5M | Buy |
729,504
+9,900
| +1% | +$420K | 2.01% | 26 |
|
|
2024
Q4 | $20M | Hold |
719,604
| – | – | 1.53% | 31 |
|
|
2024
Q3 | $20.6M | Hold |
719,604
| – | – | 1.83% | 26 |
|
|
2024
Q2 | $16.9M | Buy |
719,604
+391,000
| +119% | +$8.36M | 1.75% | 29 |
|
|
2024
Q1 | $8.3M | Sell |
328,604
-181,396
| -36% | -$4.36M | 0.96% | 50 |
|
|
2023
Q4 | $11.9M | Buy |
510,000
+366,000
| +254% | +$7.22M | 1.54% | 32 |
|
|
2023
Q3 | $7.28M | Hold |
144,000
| – | – | 1.04% | 46 |
|
|
2023
Q2 | $6.72M | Sell |
144,000
-20,000
| -12% | -$917K | 1.02% | 48 |
|
|
2023
Q1 | $6.27M | Hold |
164,000
| – | – | 1.01% | 46 |
|
|
2022
Q4 | $8.99M | Sell |
164,000
-128,000
| -44% | -$5.48M | 1.48% | 34 |
|
|
2022
Q3 | $9.94M | Buy |
292,000
+2,000
| +0.7% | +$30.6K | 2.16% | 16 |
|
|
2022
Q2 | $2.74M | Buy |
+290,000
| New | +$3.02M | 0.55% | 55 |
|
